{"sha1": "80c00a5b5e27767fa63b7b6879b35d656c7941de", "filename_exif": "4138.txt", "extension_exif": "TXT", "last_modified_exif": "2021:09:23 16:30:10+10:00", "create_date_exif": null, "access_date_exif": "2023:09:23 14:24:05+10:00", "modify_date_exif": "2021:09:23 16:30:10+10:00", "mime_type_exif": "text/plain", "file_size_exif": 17802, "title_exif": "", "path_components_exif": ["data", "medical_papers"], "publication_date_exif": "", "author_exif": "", "organizational_unit_exif": "", "content": "\n\n\n\n\n\n\n\n\n\n\u7b2c9\u5377\u7b2c4\u671f2018\u5e747\u6708Vol.9No.4Jul.2018\u5668\u5b98\u79fb\u690dOrganTransplantation\u3010\u6458\u8981\u3011\u76ee\u7684\u63a2\u8ba8\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u6cbb\u7597\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408\u5f81\uff08BOS\uff09\u5408\u5e76\u6f0f\u6597\u80f8\u7684\u7597\u6548\u3002\u65b9\u6cd52015\u5e743\u670824\u65e5\uff0c1\u4f8b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u5408\u5e76\u6f0f\u6597\u80f8\u60a3\u8005\u5728\u5357\u4eac\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u65e0\u9521\u5e02\u4eba\u6c11\u533b\u9662\u80f8\u5916\u79d1\u66a8\u80ba\u79fb\u690d\u4e2d\u5fc3\u63a5\u53d7\u4f53\u5916\u819c\u80ba\u6c27\u5408\uff08ECMO\uff09\u8f85\u52a9\u4e0b\u53cc\u80ba\u79fb\u690d\u672f\uff0c\u540c\u671f\u884cNuss\u624b\u672f\u77eb\u6cbb\u6f0f\u6597\u80f8\uff0c\u624b\u672f\u987a\u5229\uff0c\u672f\u540e\u4e88\u6297\u708e\u3001\u6297\u771f\u83cc\u9884\u9632\u6cbb\u7597\uff0c\u4e88\u4ed6\u514b\u83ab\u53f8+\u5417\u66ff\u9ea6\u8003\u915a\u916f+\u80be\u4e0a\u817a\u76ae\u8d28\u6fc0\u7d20\u4e09\u8054\u514d\u75ab\u6291\u5236\u65b9\u6848\u6cbb\u7597\u3002\u7ed3\u679c\u60a3\u8005\u672f\u540e\u6062\u590d\u987a\u5229\uff0c\u4e8e\u672f\u540e25d\u51fa\u9662\uff0c\u672f\u540e2\u5e74\u62c6\u9664\u80f8\u90e8Nuss\u94a2\u677f\uff0c\u80f8\u5ed3\u7578\u5f62\u5f97\u5230\u7ea0\u6b63\uff0c\u672f\u540e\u63a5\u53d7\u957f\u671f\u968f\u8bbf\uff0c\u622a\u6b62\u81f3\u6295\u7a3f\u65e5\uff0c\u60a3\u8005\u5b58\u6d3b3\u5e74\u4f59\uff0c\u80ba\u529f\u80fd\u6062\u590d\u826f\u597d\uff0c\u751f\u6d3b\u8d28\u91cf\u6ee1\u610f\u3002\u7ed3\u8bba\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u662f\u6cbb\u7597\u7ec8\u672b\u671fBOS\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u7684\u6709\u6548\u529e\u6cd5\u3002\u3010\u5173\u952e\u8bcd\u3011\u80ba\u79fb\u690d\uff1b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\uff1b\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\uff1b\u77eb\u6cbb\u672f\uff1b\u80f8\u5ed3\u7578\u5f62\uff1b\u6f0f\u6597\u80f8\uff1b\u4f53\u5916\u819c\u80ba\u6c27\u5408\u3010\u4e2d\u56fe\u5206\u7c7b\u53f7\u3011R617\uff0cR563\uff0cR682\u3010\u6587\u732e\u6807\u5fd7\u7801\u3011A\u3010\u6587\u7ae0\u7f16\u53f7\u30111674-7445\uff082018\uff0904-0005-05\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u6cbb\u7597\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408\u5f81\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u957f\u671f\u751f\u5b581\u4f8b\u4e01\u6d69\u6bdb\u6587\u541b\u5218\u5cf0\u8303\u7acb\u9648\u9759\u745c\u00b7\u4e34\u5e8a\u7814\u7a76\u00b7Long-termsurvivalofbilaterallungtransplantationcombinedwithNussoperationontreatmentofbronchiolitisobliteranssyndromecomplicatedwiththoracicdeformityafterhematopoieticstemcelltransplantation:reportofonecaseDingHao,MaoWenjun,LiuFeng,FanLi,ChenJingyu.DepartmentofThoracicSurgeryandLungTransplantationCenter,WuxiPeople'sHospitalAffiliatedtoNanjingMedicalUniversity,Wuxi214023,ChinaCorrespondingauthor:ChenJingyu,Email:chenjingyu333@sina.comDOI:10.3969/j.issn.1674-7445.2018.04.005\u57fa\u91d1\u9879\u76ee\uff1a\u6c5f\u82cf\u7701\u79d1\u6559\u5f3a\u536b\u5de5\u7a0b\u9752\u5e74\u533b\u5b66\u91cd\u70b9\u4eba\u624d\u9879\u76ee\uff08QNRC2016193\uff09\uff1b\u5357\u4eac\u533b\u79d1\u5927\u5b66\u79d1\u6280\u53d1\u5c55\u57fa\u91d1\u9762\u4e0a\u9879\u76ee\uff082015NJMU146\uff09\u4f5c\u8005\u5355\u4f4d\uff1a214023\u6c5f\u82cf\u65e0\u9521\uff0c\u5357\u4eac\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u65e0\u9521\u5e02\u4eba\u6c11\u533b\u9662\u80f8\u5916\u79d1\u66a8\u80ba\u79fb\u690d\u4e2d\u5fc3\u4f5c\u8005\u7b80\u4ecb\uff1a\u4e01\u6d69\uff0c\u7537\uff0c1993\u5e74\u751f\uff0c\u7855\u58eb\u7814\u7a76\u751f\uff0c\u7814\u7a76\u65b9\u5411\u4e3a\u80f8\u5916\u79d1\u53ca\u80ba\u79fb\u690d\uff0cEmail\uff1a353249221@qq.com\u901a\u8baf\u4f5c\u8005\uff1a\u9648\u9759\u745c\uff0c\u7537\uff0c1963\u5e74\u751f\uff0c\u4e3b\u4efb\u533b\u5e08\uff0c\u7814\u7a76\u65b9\u5411\u4e3a\u80f8\u5916\u79d1\uff0cEmail\uff1achenjingyu333@sina.com\u3010Abstract\u3011ObjectiveToevaluatetheclinicalefficacyofbilaterallungtransplantationcombinedwithNussoperationonthetreatmentofbronchiolitisobliteranssyndrome(BOS)complicatedwithpectusexcavatumafterhematopoieticstemcelltransplantation.MethodsOnMarch24,2015,onepatientpresentingwithBOScomplicatedwithpectusexcavatumafterhematopoieticstemcelltransplantationunderwentextracorporealmembraneoxygenation(ECMO)-assistedbilaterallungtransplantationintheDepartmentofThoracicSurgeryandLungTransplantationCenterofWuxiPeople'sHospitalaffiliatedtoNanjingMedicalUniversity.Simutaneously,Nussoperationwassuccessfullyperformedtotreatpectusexcavatum.Afteranti-inflammationandanti-fungaltreatment,atripleimmunosuppressiveregimenconsistingoftacrolimus+mycophenolatemofetil+adrenocorticalhormonewasimplemented.ResultsThepatientwasproperlyrecoveredanddischargedon25dafteroperation.TheNusssteelplatewasremovedfromthechestatpostoperative2years.Thethoracicdeformitywascorrected.Thepatientreceivedlong-termpostoperativefollow-up.Untilsubmissiondate,thepatientsurvivedformorethan3years.Thelungfunctionwaswellrestoredandthequalityoflifewassatisfactory.ConclusionsBilaterallungtransplantationcombinedwithNussoperationisaneffectiveapproachinthetreatmentofend-stageBOScomplicatedthoracicdeformity.\ufffd\u7b2c4\u671f\u00b7269\u00b7\u4e01\u6d69\u7b49\uff0e\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u6cbb\u7597\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408\u5f81\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u957f\u671f\u751f\u5b581\u4f8b\u80ba\u79fb\u690d\u662f\u6cbb\u7597\u591a\u79cd\u7ec8\u672b\u671f\u80ba\u75be\u75c5\u7684\u552f\u4e00\u6709\u6548\u65b9\u6cd5\uff0c\u6700\u4e3b\u8981\u7684\u4e24\u5927\u9002\u5e94\u8bc1\u4e3a\u7279\u53d1\u6027\u80ba\u95f4\u8d28\u7ea4\u7ef4\u5316\u548c\u6162\u6027\u963b\u585e\u6027\u80ba\u75be\u75c5\uff0c\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408\u5f81\uff08bronchiolitisobliteranssyndrome\uff0cBOS\uff09\u662f\u80ba\u79fb\u690d\u8f83\u4e3a\u7f55\u89c1\u7684\u624b\u672f\u9002\u5e94\u8bc1\u3002\u6839\u636e\u56fd\u9645\u5fc3\u80ba\u79fb\u690d\u534f\u4f1a2015\u5e74\u7684\u7edf\u8ba1\u6570\u636e\uff0c\u5168\u7403\u5df2\u5b8c\u621051440\u591a\u4f8b\u80ba\u79fb\u690d\u624b\u672f\uff0c\u80ba\u79fb\u690d\u672f\u540e3\u4e2a\u6708\u30011\u5e74\u30013\u5e74\u30015\u5e74\u300110\u5e74\u7684\u5b58\u6d3b\u7387\u5206\u522b\u4e3a89%\u300180%\u300165%\u300154%\u548c31%\u3002\u80ba\u79fb\u690d\u53d7\u4f53\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u5bf9\u79fb\u690d\u79d1\u533b\u5e08\u662f\u4e00\u5927\u6311\u6218\uff0c\u80f8\u5ed3\u7578\u5f62\u4e0d\u4ec5\u52a0\u5927\u4e86\u79fb\u690d\u624b\u672f\u96be\u5ea6\uff0c\u672f\u540e\u4e3a\u6062\u590d\u80ba\u529f\u80fd\uff0c\u8fd8\u9700\u8981\u5bf9\u60a3\u8005\u8fdb\u884c\u80f8\u58c1\u77eb\u6cbb\u672f\uff0c\u4ee5\u4fbf\u4f9b\u80ba\u4e0e\u80f8\u8154\u5bb9\u79ef\u5339\u914d\u3002\u672c\u6587\u5bf91\u4f8b\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u7684BOS\u60a3\u8005\u5b9e\u65bd\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u7684\u7ecf\u9a8c\u8fdb\u884c\u603b\u7ed3\uff0c\u62a5\u9053\u5982\u4e0b\u30021\u4e34\u5e8a\u8d44\u6599\u60a3\u8005\uff0c\u5973\uff0c39\u5c81\uff0c\u4f53\u8d28\u91cf48kg\uff0c\u8eab\u9ad8160cm\u3002\u56e0\u6025\u6027B\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c52008\u5e7412\u670818\u65e5\u4e8e\u5317\u4eac\u5927\u5b66\u4eba\u6c11\u533b\u9662\u884c\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u30022009\u5e744\u6708\u51fa\u73b0\u76ae\u80a4\u79fb\u690d\u7269\u6297\u5bbf\u4e3b\u75c5\uff08GVHD\uff09\uff0c2009\u5e749\u6708\u51fa\u73b0\u809d\u810fGVHD\uff0c2010\u5e7410\u6708\u51fa\u73b0\u6d3b\u52a8\u540e\u6c14\u5598\uff0c\u6309\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u6cbb\u7597\uff0c2012\u5e749\u6708\u53d7\u4f53\u7ecf\u5317\u4eac\u5927\u5b66\u4eba\u6c11\u533b\u9662\u3001\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\u7b49\u8054\u5408\u4f1a\u8bca\uff0c\u786e\u8bca\u4e3a\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u3002\u60a3\u8005\u5e76\u53d1\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u540e\uff0c\u7578\u5f62\u7f13\u6162\u8fdb\u5c55\uff0c\u9010\u6e10\u51fa\u73b0\u80f8\u9aa8\u5185\u51f9\uff0c\u6700\u540e\u53d1\u5c55\u4e3a\u5178\u578b\u7684\u6f0f\u6597\u80f8\u8868\u73b0\u3002\u60a3\u8005\u4e8e2015\u5e742\u67089\u65e5\u4e8e\u5357\u4eac\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u65e0\u9521\u5e02\u4eba\u6c11\u533b\u9662\u884c\u80ba\u79fb\u690d\u8bc4\u4f30\uff0c\u63a5\u53d7\u7684\u68c0\u67e5\u5305\u62ec\u80f8\u90e8CT\u68c0\u67e5\uff08\u56fe1A\u3001B\uff09\u3001\u5fc3\u810f\u5f69\u8272\u591a\u666e\u52d2\u8d85\u58f0\u3001\u5e8a\u8fb9\u80ba\u529f\u80fd\u68c0\u67e5\u3001\u4f53\u683c\u68c0\u67e5\u4ee5\u53ca\u5176\u4ed6\u5b9e\u9a8c\u5ba4\u76f8\u5173\u68c0\u67e5\uff0c\u8bca\u65ad\u4e3a\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u3001\u6f0f\u6597\u80f8\u3001\u53cc\u4fa7\u80a1\u9aa8\u5934\u574f\u6b7b\u3002\u5e8a\u8fb9\u80ba\u529f\u80fd\u663e\u793a\uff1a\u80ba\u6d3b\u91cf\uff08vitalcapacity\uff0cVC\uff090.8L\uff0c\u5b9e\u6d4b\u503c/\u9884\u6d4b\u503c\u4e3a26%\uff1b\u7b2c1\u79d2\u7528\u529b\u547c\u6c14\u5bb9\u79ef\uff08forcedexpiratoryvolumeinonesecond\uff0cFEV1.0\uff090.65L\uff0c\u5b9e\u6d4b\u503c/\u9884\u6d4b\u503c\u4e3a25%\uff0cFEV1.0/\u7528\u529b\u80ba\u6d3b\u91cf\uff08forcedvitalcapacity\uff0cFVC\uff0982%\u3002\u8840\u6c14\u5206\u6790\uff1apH\u503c7.43\uff0c\u52a8\u8109\u8840\u6c27\u5206\u538b\uff08PaO2\uff0982mmHg\uff0810mmHg=1.33kPa\uff09\uff0c\u52a8\u8109\u8840\u4e8c\u6c27\u5316\u78b3\u5206\u538b\uff08PaCO2\uff0950mmHg\uff0c\u78b3\u9178\u6c22\u76d0\uff08HCO3-\uff0932mmol/L\uff0c\u52a8\u8109\u8840\u6c27\u9971\u548c\u5ea6\uff08SaO2\uff0996%\uff0c\u5438\u5165\u6c27\u6d53\u5ea6\uff08FiO2\uff0921%\u3002\u7ecf\u6211\u9662\u4f26\u7406\u59d4\u5458\u4f1a\u8ba8\u8bba\u901a\u8fc7\uff0c\u60a3\u8005\u8fdb\u5165\u80ba\u79fb\u690d\u7b49\u5f85\u540d\u5355\uff0c\u5f85\u4f9b\u80ba\u8fdb\u884c\u53cc\u80ba\u79fb\u690d\u540c\u671f\u505aNuss\u94a2\u677f\u77eb\u6cbb\u672f\u30022015\u5e743\u670824\u65e5\u5339\u914d\u5408\u9002\u4f9b\u4f53\u8fdb\u884c\u624b\u672f\u6cbb\u7597\u3002\u80ba\u79fb\u690d\u4f9b\u4f53\uff0c\u5973\uff0c35\u5c81\uff0c\u4f53\u8d28\u91cf61kg\uff0c\u8eab\u9ad8163cm\u3002\u5e73\u65f6\u8eab\u4f53\u5065\u5eb7\uff0c\u56e0\u9885\u8111\u52a8\u8109\u7624\u7834\u88c2\u88ab\u660e\u786e\u5224\u5b9a\u4e3a\u8111\u6b7b\u4ea1\uff0c\u4f9b\u4f53\u7684\u8fd1\u4eb2\u4eb2\u5c5e\u5747\u77e5\u60c5\u540c\u610f\u6350\u732e\u5668\u5b98\u3002\u4f9b\u4f53\u65e0\u5fc3\u3001\u80ba\u75be\u75c5\u75c5\u53f2\uff0c\u4f9b\u4f53\u548c\u53d7\u4f53ABO\u3001Rh\u8840\u578b\u76f8\u540c\uff0c\u4f53\u578b\u3001\u80f8\u56f4\u5339\u914d\uff0c\u7fa4\u4f53\u53cd\u5e94\u6027\u6297\u4f53\uff08PRA\uff09\u53ca\u4eba\u7c7b\u767d\u7ec6\u80de\u6297\u539f\uff08HLA\uff09\u5747\u4e3a\u9634\u6027\u3002\u6309\u89c4\u8303\u5207\u53d6\u4f9b\u80ba\uff0c\u91c7\u7528\u68c9\u5b50\u7cd6\u4f4e\u94be\u53f3\u65cb\u7cd6\u9150\u6db2\uff08raffinose-lowpotassiumdextransolution\uff0cRLPD\u6db2\uff09\u704c\u6ce8\u5e76\u4fdd\u5b58\u8f6c\u8fd0\u4f9b\u80ba[1]\u3002\u53d7\u4f53\u5168\u8eab\u9ebb\u9189\u540e\u53cc\u8154\u7ba1\u6c14\u7ba1\u63d2\u7ba1\uff0c\u60a3\u8005\u53d6\u4ef0\u5367\u4f4d\uff0c\u4f53\u5916\u819c\u80ba\u6c27\u5408\uff08ECMO\uff09\u8f85\u52a9\u91c7\u7528\u53f3\u4fa7\u80a1\u9759\u8109-\u52a8\u8109\uff08venous-artery\uff0cV-A\uff09\u63d2\u7ba1\u6a21\u5f0f\uff0cECMO\u4f7f\u7528\u65b9\u6848\u8be6\u89c1\u6587\u732e[2]\u3002\u5728\u80f8\u5ed3\u51f9\u9677\u5904\u505a\u6807\u8bb0\uff0c\u65cb\u8f6c\u624b\u672f\u5e8a\u4f7f\u53f3\u80f8\u62ac\u9ad830\u00b0\uff0c\u5728\u53f3\u524d\u5916\u4fa7\u7b2c5\u808b\u95f4\u884c\u5207\u53e3\u5f00\u80f8\uff0c\u4e0d\u6a2a\u65ad\u80f8\u9aa8\uff0c\u672f\u4e2d\u63a2\u67e5\u89c1\u53f3\u80ba\u4e0e\u80f8\u8154\u90e8\u5206\u7c98\u8fde\uff0c\u53f3\u80ba\u5448\u90e8\u5206\u5b9e\u53d8\u8868\u73b0\uff0c\u7b26\u5408BOS\u8bca\u65ad\uff0c\u5207\u9664\u53f3\u80ba\uff0c\u7ebf\u6027\u53f3\u5355\u80ba\u79fb\u690d\uff0c\u5177\u4f53\u64cd\u4f5c\u65b9\u5f0f\u89c1\u6587\u732e[3]\uff0c\u9f13\u80ba\u540e\u53f3\u4f9b\u80ba\u81a8\u80c0\u660e\u663e\u53d7\u9650\uff0c\u4e0d\u5173\u80f8\u3002\u65cb\u8f6c\u624b\u672f\u5e8a\uff0c\u5de6\u80f8\u62ac\u9ad830\u00b0\uff0c\u540c\u6cd5\u5b8c\u6210\u5de6\u5355\u80ba\u79fb\u690d\u3002\u624b\u672f\u5e8a\u653e\u5e73\uff0c\u60a3\u8005\u53d6\u4ef0\u5367\u4f4d\uff0c\u5728\u6f0f\u6597\u80f8\u51f9\u9677\u6700\u4f4e\u70b9\u8fdb\u884cNuss\u94a2\u677f\u7f6e\u5165\u624b\u672f\uff0c\u4e0a\u62ac\u80f8\u9aa8\uff0c\u80f8\u8154\u5bb9\u79ef\u660e\u663e\u6269\u5927\uff0c\u89c2\u5bdf\u53cc\u80ba\u6269\u5f20\u826f\u597d\u3002\u6d4b\u91cf\u80f8\u5ed3\u5927\u5c0f\u540e\u91c7\u752814\u82f1\u5bf8\u77eb\u6cbb\u94a2\u677f1\u6839\uff0c\u5c06\u94a2\u677f\u4e24\u7aef\u7528\u56fa\u5b9a\u7247\u56fa\u5b9a\u5728\u5de6\u53f3\u7b2c7\u808b\u95f4[4]\u3002\u53cc\u4fa7\u9010\u5c42\u5173\u80f8\u3002\u672f\u4e2d\u53f3\u80ba\u51b7\u7f3a\u8840\u65f6\u95f4168min\uff0c\u5de6\u80ba\u51b7\u7f3a\u8840\u65f6\u95f4290min\u3002\u80ba\u79fb\u690d\u672f\u540e\u89c2\u5bdf\u79fb\u690d\u80ba\u529f\u80fd\u826f\u597d\uff0c\u6c27\u5408\u6ee1\u610f\uff0c\u5faa\u73af\u7a33\u5b9a\uff0c\u64a4\u79bbECMO\u5165\u91cd\u75c7\u76d1\u62a4\u5ba4\uff08ICU\uff09\u7ee7\u7eed\u76d1\u62a4\u6cbb\u7597\u3002\u672f\u540e\u4e88\u6297\u708e\u3001\u6297\u771f\u83cc\u9884\u9632\u6cbb\u7597\uff0c\u5e76\u540c\u65f6\u4e88\u5e38\u89c4\u4ed6\u514b\u83ab\u53f8+\u5417\u66ff\u9ea6\u8003\u915a\u916f+\u80be\u4e0a\u817a\u76ae\u8d28\u6fc0\u7d20\uff08\u6fc0\u7d20\uff09\u4e09\u8054\u514d\u75ab\u6291\u5236\u6cbb\u7597\u3002\u53d7\u4f53\u4e8e\u672f\u540e6h\u6e05\u9192\uff0c\u672f\u540e2d\u62d4\u9664\u6c14\u7ba1\u63d2\u7ba1\uff0c\u672f\u540e3d\u8f6c\u51faICU\uff0c\u672f\u540e7d\u590d\u67e5\u80f8\u90e8CT\u793a\u53cc\u80ba\u6e05\u6670\uff0c\u80ba\u6269\u5f20\u826f\u597d\uff08\u56fe1C\u3001D\uff09\u3002\u60a3\u8005\u4e8e\u672f\u540e25d\u5eb7\u590d\u51fa\u9662\u3002\u60a3\u8005\u672f\u540e2\u5e74\u590d\u67e5X\u7ebf\u80f8\u7247\u793a\uff1a\u53cc\u80ba\u79fb\u690d\u672f\u540e\uff0c\u3010Keywords\u3011Lungtransplantation;Hematopoieticstemcelltransplantation;Bronchiolitisobliterans;Correctionsurgery;Thoracicdeformity;Pectusexcavatum;Extracorporealmembraneoxygenation\ufffd\u00b7270\u00b7\u7b2c9\u5377\u5668\u5b98\u79fb\u690d\u80f8\u5ed3\u5916\u56fa\u5b9a\u4e2d\uff0c\u80ba\u6269\u5f20\u901a\u6c14\u826f\u597d\uff0c\u672a\u89c1\u660e\u663e\u80f8\u5ed3\u7578\u5f62\uff08\u56fe2A\u3001B\uff09\u30022017\u5e744\u670810\u65e5\u5728\u5168\u8eab\u9ebb\u9189\u4e0b\u884cNuss\u94a2\u677f\u62c6\u9664\u672f\uff0c\u624b\u672f\u987a\u5229\uff0c\u590d\u67e5X\u7ebf\u80f8\u7247\u793a\uff1a\u53cc\u80ba\u79fb\u690d\u672f\u540e\uff0c\u80f8\u5ed3\u5916\u56fa\u5b9a\u53d6\u51fa\u672f\u540e\uff0c\u80f8\u5ed3\u7578\u5f62\u5f97\u5230\u7ea0\u6b63\uff08\u56fe2C\uff09\u3002\u60a3\u8005\u672f\u540e\u63a5\u53d7\u957f\u671f\u968f\u8bbf\uff0c\u672f\u540e744d\u590d\u67e5\u53d7\u4f53\u80ba\u529f\u80fd\u826f\u597d\uff0c\u80f8\u90e8CT\u793a\u53cc\u4fa7\u79fb\u690d\u80ba\u7eb9\u7406\u6e05\u6670\uff0c\u672a\u89c1\u660e\u663e\u80f8\u5ed3\u7578\u5f62\u3002\u80ba\u529f\u80fd\u68c0\u67e5\u663e\u793a\uff1aFEV1.02.06L\uff0c\u5b9e\u6d4b\u503c/\u9884\u6d4b\u503c\u4e3a93%\uff0cFEV1.0/FVC99%\uff1b\u80ba\u4e00\u6c27\u5316\u78b3\u5f25\u6563\u56e0\u5b50\uff08transferfactorforcarbonmonoxideoflung\uff0cTLCO\uff09\u5355\u6b21\u547c\u5438\u6cd5\uff08singlebreath\uff0cSB\uff09\u5b9e\u6d4b\u503c/\u9884\u6d4b\u503c\u4e3a59%\uff1bTLCO/\u80ba\u6ce1\u901a\u6c14\u91cf\uff08alveolarventilation\uff0cVA\uff0955%\u3002\u7ea4\u7ef4\u652f\u6c14\u7ba1\u955c\u68c0\u67e5\u793a\u543b\u5408\u53e3\u826f\u597d\uff0c\u672a\u89c1\u660e\u663e\u72ed\u7a84\u3002\u622a\u6b62\u81f3\u6295\u7a3f\u65e5\uff0c\u60a3\u8005\u5b58\u6d3b3\u5e74\u4f59\uff0c\u80ba\u529f\u80fd\u6062\u590d\u826f\u597d\uff0c\u751f\u6d3b\u8d28\u91cf\u6ee1\u610f\u3002A\u56fe\u4e3aNuss\u94a2\u677f\u62c6\u9664\u524d\u6b63\u4f4dX\u7ebf\u80f8\u7247\uff1bB\u56fe\u4e3aNuss\u94a2\u677f\u62c6\u9664\u524d\u4fa7\u4f4dX\u7ebf\u80f8\u7247\uff1bC\u56fe\u4e3aNuss\u94a2\u677f\u62c6\u9664\u540e\u6b63\u4f4dX\u7ebf\u80f8\u7247\u56fe2\u672c\u4f8b\u53d7\u4f53Nuss\u94a2\u677f\u62c6\u9664\u524d\u540e\u7684X\u7ebf\u80f8\u7247Figure2X-raychestradiographsoftherecipientbeforeandafterremovingNusssteelplateABCA\u3001B\u56fe\u4e3a\u672f\u524d\u80f8\u90e8CT\u68c0\u67e5\u56fe\u7247\uff1bC\u3001D\u56fe\u4e3a\u672f\u540e\u80f8\u90e8CT\u68c0\u67e5\u56fe\u7247\u56fe1\u672c\u4f8b\u53d7\u4f53\u53cc\u80ba\u79fb\u690d\u672f\u524d\u540e\u80f8\u90e8CT\u68c0\u67e5\u7ed3\u679cFigure1ResultsofchestCTexaminationoftherecipientbeforeandafterbilaterallungtransplantationACBD\ufffd\u7b2c4\u671f\u00b7271\u00b7\u4e01\u6d69\u7b49\uff0e\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u6cbb\u7597\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u95ed\u585e\u6027\u7ec6\u652f\u6c14\u7ba1\u708e\u7efc\u5408\u5f81\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u957f\u671f\u751f\u5b581\u4f8b2\u8ba8\u8bba\u8fd1\u5e74\u6765\uff0c\u968f\u7740\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u6280\u672f\u7684\u65e5\u76ca\u6210\u719f\uff0c\u60a3\u8005\u672f\u540e\u5b58\u6d3b\u7387\u660e\u663e\u63d0\u9ad8\uff0c\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u88ab\u5e7f\u6cdb\u5e94\u7528\u4e8e\u6cbb\u7597\u591a\u79cd\u80bf\u7624\u3001\u8840\u6db2\u75c5\u548c\u9057\u4f20\u6027\u75be\u75c5[5-6]\u3002\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u8fdc\u671f\u5e76\u53d1\u75c7\u4e3b\u8981\u662fBOS\uff0c\u5176\u53d1\u751f\u7387\u4e3a2%~5%[7-8]\u3002\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u75c5\u6b7b\u7387\u9ad8\u8fbe60%\uff0c\u56e0\u6b64\u76ee\u524d\u80ba\u90e8\u5e76\u53d1\u75c7\u662f\u5bfc\u81f4\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u53d7\u4f53\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0[9]\u3002\u5f53\u6b64\u7c7b\u60a3\u8005\u5728\u63a5\u53d7\u4fdd\u5b88\u6cbb\u7597\u5931\u8d25\u75c5\u60c5\u52a0\u901f\u8fdb\u5c55\u7684\u60c5\u51b5\u4e0b\uff0c\u5e94\u8003\u8651\u80ba\u79fb\u690d\uff0c\u80ba\u79fb\u690d\u662f\u6cbb\u7597\u7ec8\u672b\u671fBOS\u7684\u6709\u6548\u65b9\u6cd5[10]\u3002\u6f0f\u6597\u80f8\u662f\u80f8\u5916\u79d1\u5e38\u89c1\u7684\u80f8\u5ed3\u7578\u5f62\uff0c\u4e3b\u8981\u8868\u73b0\u4e3a\u80f8\u9aa8\u53ca\u76f8\u8fde\u7684\u808b\u8f6f\u9aa8\u5411\u5185\u51f9\u9677\uff0c\u5bf9\u5fc3\u810f\u53ca\u80ba\u7ec4\u7ec7\u4ea7\u751f\u538b\u8feb\u548c\u63a8\u79fb\uff0c\u60a3\u8005\u4f1a\u9010\u6e10\u51fa\u73b0\u6d3b\u52a8\u8010\u529b\u4e0b\u964d\u3001\u5fc3\u614c\u3001\u6c14\u77ed\uff0c\u5e76\u4e14\u968f\u7740\u5e74\u9f84\u589e\u957f\uff0c\u60a3\u8005\u51fa\u73b0\u5404\u79cd\u75c7\u72b6\u7684\u53ef\u80fd\u6027\u968f\u4e4b\u589e\u52a0[11-12]\uff0c\u80f8\u5ed3\u7578\u5f62\u7684\u5b58\u5728\u5bf9\u60a3\u8005\u7684\u751f\u7406\u4e0e\u5fc3\u7406\u4ea7\u751f\u91cd\u5927\u5f71\u54cd\uff0c\u800c\u77eb\u5f62\u624b\u672f\u662f\u6cbb\u7597\u6f0f\u6597\u80f8\u7684\u552f\u4e00\u529e\u6cd5\u3002\u672c\u4f8b\u60a3\u8005\u4e3a\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u5408\u5e76\u6f0f\u6597\u80f8\uff0c\u7b14\u8005\u6587\u732e\u68c0\u7d22\u540e\uff0c\u53d1\u73b0\u6b64\u7c7b\u75c5\u4f8b\u6682\u65e0\u6587\u732e\u62a5\u9053\u5176\u6cbb\u7597\u7ecf\u9a8c\uff0c\u56e0\u6b64\u672c\u4f8b\u62a5\u9053\u6709\u8f83\u597d\u7684\u4e34\u5e8a\u610f\u4e49\u3002\u6839\u636e\u53d7\u4f53\u4e34\u5e8a\u8d44\u6599\uff0c\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u524d\u672a\u51fa\u73b0\u6f0f\u6597\u80f8\uff0c\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540e\u5e76\u53d1BOS\u9010\u6e10\u51fa\u73b0\u80f8\u9aa8\u5185\u51f9\uff0c\u8fdb\u5c55\u4e3a\u6f0f\u6597\u80f8\uff0c\u8003\u8651\u6f0f\u6597\u80f8\u7684\u53d1\u751f\u4e0e\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u53d1\u75c5\u6709\u5173\uff0cGVHD\u7684\u9776\u5668\u5b98\u4e3b\u8981\u4e3a\u80ba\uff0c\u80f8\u9aa8\u3001\u808b\u9aa8\u548c\u808b\u8f6f\u9aa8\u53ef\u80fd\u4e5f\u662f\u53d7\u5176\u5f71\u54cd\u3002\u6b64\u4f8b\u60a3\u8005\u4e3a\u7f55\u89c1\u75c5\u4f8b\uff0c\u5904\u7406\u4e0d\u540c\u4e8e\u5e38\u89c4\u80ba\u79fb\u690d\uff0c\u5982\u4f55\u9009\u62e9\u6b63\u786e\u7684\u624b\u672f\u6cbb\u7597\u65b9\u5f0f\u5bf9\u5916\u79d1\u533b\u5e08\u6765\u8bf4\u662f\u4e00\u5927\u6311\u6218\uff0c\u672c\u4f8b\u4e2d\u6211\u9662\u91c7\u7528\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u6cbb\u7597\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u672f\u540eBOS\u5408\u5e76\u6f0f\u6597\u80f8\u3002\u80ba\u79fb\u690d\u624b\u672f\u672c\u8eab\u5bf9\u53d7\u4f53\u80f8\u8154\u5bb9\u79ef\u7684\u5927\u5c0f\u8981\u6c42\u9ad8\uff0c\u80f8\u8154\u5bb9\u79ef\u5c0f\u4e0d\u5229\u4e8e\u690d\u5165\u80ba\u7684\u81a8\u80c0\uff0c\u5bf9\u4e8e\u5c0f\u80f8\u8154\u3001\u5927\u4f9b\u80ba\u7684\u60a3\u8005\uff0c\u5e38\u9700\u80ba\u51cf\u5bb9\u4ee5\u9002\u5e94\u4f9b\u3001\u53d7\u4f53\u5bb9\u79ef\u5339\u914d\uff0c\u672c\u4f8b\u4f9b\u3001\u53d7\u4f53\u4f53\u578b\u5927\u5c0f\u5339\u914d\uff0c\u4f46\u53d7\u4f53\u6f0f\u6597\u80f8\uff0c\u80f8\u8154\u5bb9\u79ef\u5c0f\uff0c\u5982\u679c\u4e0d\u884c\u80f8\u5ed3\u7578\u5f62\u7ea0\u6b63\uff0c\u4f9b\u80ba\u9700\u8981\u51cf\u5bb9\uff0c\u672f\u540e\u6f0f\u6597\u80f8\u4ecd\u5f97\u4e0d\u5230\u7ea0\u6b63\uff0c\u5f71\u54cd\u5916\u89c2\uff0c\u538b\u8feb\u5fc3\u810f\u548c\u80ba\u7ec4\u7ec7\uff0c\u5f71\u54cd\u672f\u540e\u7684\u5fc3\u3001\u80ba\u529f\u80fd\u3002\u80ba\u79fb\u690d\u540c\u65f6\u8fdb\u884cNuss\u624b\u672f\uff0c\u6b64\u624b\u672f\u7b80\u5355\u65b9\u4fbf\uff0c\u4e0d\u989d\u5916\u589e\u52a0\u624b\u672f\u5207\u53e3\uff0c\u672f\u540e\u80f8\u8154\u5bb9\u79ef\u6269\u5927\u660e\u663e\uff0c\u4f9b\u80ba\u6269\u5f20\u826f\u597d\uff0c\u6700\u5927\u9650\u5ea6\u5730\u4fdd\u7559\u4e86\u60a3\u8005\u672f\u540e\u80ba\u529f\u80fd\u3002\u7efc\u4e0a\u6240\u8ff0\uff0c\u53cc\u80ba\u79fb\u690d\u540c\u671fNuss\u624b\u672f\u6cbb\u7597\u7ec8\u672b\u671f\u80ba\u75c5\u5408\u5e76\u80f8\u5ed3\u7578\u5f62\u6f0f\u6597\u80f8\u53ef\u53d6\u5f97\u826f\u597d\u7684\u7597\u6548\uff0c\u60a3\u8005\u672f\u540e\u80ba\u529f\u80fd\u6062\u590d\u826f\u597d\uff0c\u751f\u6d3b\u8d28\u91cf\u6ee1\u610f\u3002[1]\u6bdb\u6587\u541b\uff0c\u9648\u9759\u745c\uff0c\u90d1\u660e\u5cf0\uff0c\u7b49\uff0e\u68c9\u5b50\u7cd6\u4f4e\u94be\u53f3\u65cb\u7cd6\u9150\u6db2\u5728\u4e34\u5e8a\u80ba\u79fb\u690d\u4e2d\u7684\u5e94\u7528[J]\uff0e\u4e2d\u534e\u5668\u5b98\u79fb\u690d\u6742\u5fd7\uff0c2012,33(5):275-279.DOI:10.3760/cma.j.issn.0254-1785.2012.05.005.MAOWJ,CHENJY,ZHENGMF,etal.Raffinose-lowpotassiumdextransolutioninclinicallungtransplantation:aretrospectivestudy[J].ChinJOrganTransplant,2012,33(5):275-279.DOI:10.3760/cma.j.issn.0254-1785.2012.05.005.[2]\u6731\u5e78\u6ca8\uff0c\u9648\u9759\u745c\uff0c\u90d1\u660e\u5cf0\uff0c\u7b49\uff0e\u4f53\u5916\u819c\u80ba\u6c27\u5408\u5728\u539f\u53d1\u6027\u53ca\u7ee7\u53d1\u6027\u80ba\u52a8\u8109\u9ad8\u538b\u80ba\u79fb\u690d\u4e2d\u7684\u5e94\u7528[J]\uff0e\u4e2d\u534e\u5668\u5b98\u79fb\u690d\u6742\u5fd7\uff0c2010,31(8):463-465.DOI:10.3760/cma.j.issn.0254-1785.2010.08.005.ZHUXF,CHENJY,ZHENGMF,etal.Lungtransplantationwithextracorporealmembraneoxygenationfortheendstagelungdiseasewithprimaryorsecondarypulmonaryhypertension[J].ChinJOrganTransplant,2010,31(8):463-465.DOI:10.3760/cma.j.issn.0254-1785.2010.08.005.[3]\u9648\u9759\u745c\uff0e\u80f8\u90e8\u5fae\u521b\u6280\u672f\u5728\u80ba\u79fb\u690d\u5207\u53e3\u4e2d\u7684\u5e94\u7528[J]\uff0e\u4e2d\u56fd\u5fae\u521b\u5916\u79d1\u6742\u5fd7\uff0c2006,6(9):648-649.DOI:10.3969/j.issn.1009-6604.2006.09.003.CHENJY.Applicationofminimallyinvasivetechniqueofchestinlungtransplantationincision[J].ChinJMinimInvasSurg,2006,6(9):648-649.DOI\uff1a10.3969/j.issn.1009-6604.2006.09.003.[4]\u5218\u6587\u4eae\uff0c\u55bb\u98ce\u96f7\uff0c\u5c39\u90a6\u826f\uff0e\u7535\u89c6\u80f8\u8154\u955c\u8f85\u52a9NUSS\u624b\u672f\u5fae\u521b\u6cbb\u7597\u6f0f\u6597\u80f8[J]\uff0e\u4e2d\u5357\u5927\u5b66\u5b66\u62a5\uff08\u533b\u5b66\u7248\uff09\uff0c2008,33(5):443-447.DOI:10.3321/j.issn:1672-7347.2008.05.013.LIUWL,YUFL,YINBL.NUSSprocedurebyvideo-assistedthoracoscopyforcorrectionofpectusexcavatum[J].JCentrSouthUniv(MedSci),2008,33(5):443-447.DOI:10.3321/j.issn:1672-7347.2008.05.013.[5]GOOLEYTA,CHIENJW,PERGAMSA,etal.Reducedmortalityafterallogeneichematopoietic-celltransplantation[J].NEnglJMed,2010,363(22):2091-2101.DOI:10.1056/NEJMoa1004383.[6]\u8096\u626c\uff0c\u8096\u6d69\u6587\uff0e\u975e\u8840\u7f18\u9020\u8840\u5e72\u7ec6\u80de\u79fb\u690d\u73b0\u72b6\u3001\u56f0\u96be\u53ca\u5904\u7406\u7b56\u7565[J]\uff0e\u5b9e\u7528\u533b\u5b66\u6742\u5fd7\uff0c2016,32(1):4-8.DOI:10.3969/j.issn.1006-5725.2016.01.002.XIAOY,XIAOHW.Status,dif\ufb01cultiesandtreatmentofnon-bloodhematopoieticstemcelltransplantation[J].JPractMed,2016,32(1):4-8.DOI:10.3969/j.issn.1006-5725.2016.01.002.\uff08\u4e0b\u8f6c\u7b2c277\u9875topage277\uff09\u53c2\u8003\u6587\u732e\uff1a\ufffd\u7b2c4\u671f\u80e1\u6797\u6606\u7b49\uff0e\u6291\u708e\u56e0\u5b50IL-35\u4e0e\u79fb\u690d\u80be\u529f\u80fd\u5ef6\u8fdf\u6062\u590d\u5173\u7cfb\u7684\u7814\u7a76\u00b7277\u00b7genetherapyexacerbatesexperimentalrheumatoidarthritisinmice[J].Cytokine,2014,69(1):87-93.DOI:10.1016/j.cyto.2014.05.015.[18]JAFARZADEHA,JAMALIM,MAHDAVIR,etal.Circulatinglevelsofinterleukin-35inpatientswithmultiplesclerosis:evaluationofthein\ufb02uencesofFOXP3genepolymorphismandtreatmentprogram[J].JMolNeurosci,2015,55(4):891-897.DOI:10.1007/s12031-014-0443-z.[19]HUY,DONGC,YUEY,etal.Invivodeliveryofinterleukin-35relievescoxsackievirus-B3-inducedviralmyocarditisbyinhibitingTh17cells[J].ArchVirol,2014,159(9):2411-2419.DOI:10.1007/s00705-014-2098-z.[20]LIUY,WUY,WANGY,etal.IL-35mitigatesmurineacutegraft-versus-hostdiseasewithretentionofgraft-versus-leukemiaeffects[J].Leukemia,2015,29(4):939-946.DOI:10.1038/leu.2014.310.\uff08\u6536\u7a3f\u65e5\u671f\uff1a2018\u201303\u201323\uff09\uff08\u672c\u6587\u7f16\u8f91\uff1a\u90ac\u52a0\u4f73\u5434\u79cb\u73b2\uff09Inflammationandmicrovasculopathyinrenalischemiareperfusioninjury[J].JTransplant,2012:764154.DOI:10.1155/2012/764154.[13]KIELARML,JOHNR,BENNETTM,etal.MaladaptiveroleofIL-6inischemicacuterenalfailure[J].JAmSocNephrol,2005,16(11):3315-3325.[14]ASCONM,ASCONDB,LIUM,etal.Renalischemia-reperfusionleadstolongtermin\ufb01ltrationofactivatedandeffector-memoryTlymphocytes[J].KidneyInt,2009,75(5):526-535.DOI:10.1038/ki.2008.602.[15]RABBH,GRIFFINMD,MCKAYDB,etal.InflammationinAKI:currentunderstanding,keyquestions,andknowledgegaps[J].JAmSocNephrol,2016,27(2):371-379.DOI:10.1681/ASN.2015030261.[16]NIEDBALAW,WEIXQ,CAIB,etal.IL-35isanovelcytokinewiththerapeuticeffectsagainstcollagen-inducedarthritisthroughtheexpansionofregulatoryTcellsandsuppressionofTh17cells[J].EurJImmunol,2007,37(11):3021-3029.[17]THIOLATA,DENYSA,PETITM,etal.Interleukin-35[7]\u674e\u864e\u660e\uff0c\u94b1\u674e\u4ec1\uff0c\u8d56\u8389\u82ac\uff0c\u7b49\uff0e\u9aa8\u9ad3\u589e\u751f\u5f02\u5e38\u7efc\u5408\u5f81\u60a3\u8005\u80ba\u529f\u80fd\u7684\u4e34\u5e8a\u7814\u7a76[J]\uff0e\u8f6c\u5316\u533b\u5b66\u6742\u5fd7\uff0c2018,7(2):86-89.DOI:10.3969/j.issn.2095-3097.2018.02.006.LIHM,QIANLR,LAILF,etal.Clinicalresearchofpulmonaryfunctioninpatientswithmyelodysplasticsyndrome[J].TranslatMedJ,2018,7(2):86-89.DOI:10.3969/j.issn.2095-3097.2018.02.006.[8]PANDYACM,SOUBANIAO.Bronchiolitisobliteransfollowinghematopoieticstemcelltransplantation:aclinicalupdate[J].ClinTransplant,2010,24(3):291-306.DOI:10.1111/j.1399-0012.2009.01122.x.[9]YOSHIHARAS,YANIKG,COOKEKR,etal.Bronchiolitisobliteranssyndrome(BOS),bronchiolitisobliteransorganizingpneumonia(BOOP),andotherlate-onsetnoninfectiouspulmonarycomplicationsfollowingallogeneichematopoieticstemcelltransplantation[J].BiolBloodMarrowTransplant,2007,13(7):749-759.[10]BOEHLERA,ESTENNEM.Obliterativebronchiolitisafterlungtransplantation[J].CurrOpinPulmMed,2000,6(2):133-139.[11]KRAGTENHA,SIEBENGAJ,H\u00d6PPENERPF,etal.Symptomaticpectusexcavatuminseniors(SPES):acardiovascularproblem?:aprospectivecardiologicalstudyof42seniorpatientswithasymptomaticpectusexcavatum[J].NethHeartJ,2011,19(2):73-78.DOI:10.1007/s12471-010-0067-z.[12]JACOBSENEB,THASTUMM,JEPPESENJH,etal.Health-relatedqualityoflifeinchildrenandadolescentsundergoingsurgeryforpectusexcavatum[J].EurJPediatrSurg,2010,20(2):85-91.DOI:10.1055/s-0029-1243621.\uff08\u6536\u7a3f\u65e5\u671f\uff1a2018\u201305\u201306\uff09\uff08\u672c\u6587\u7f16\u8f91\uff1a\u90ac\u52a0\u4f73\u5434\u79cb\u73b2\uff09\uff08\u4e0a\u63a5271\u9875frompage271\uff09\ufffd\n\n"}